-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The brain has a natural protective mechanism against Alzheimer’s disease.
The team revealed evidence supporting reactive oxygen species (ROS), which is a natural by-product of cell metabolism, is related to inflammation and other processes, and is a key factor leading to the destruction of neuroprotective mechanisms
In short, these findings provide a new mechanism for the development of Alzheimer's disease and support the idea that a combination of genetic and other cellular changes can induce this disease
When neurons face high levels of reactive oxygen species, neuroprotective mechanisms begin to work, and reactive oxygen species stimulate neurons to produce rich lipids
Previous studies have shown that two brain cell types, neurons and glial cells, work together to prevent neurodegeneration
In previous studies, the researchers linked the neuroprotective mechanism to the strongest genetic risk factor for Alzheimer's disease, the apolipoprotein APOE4
Hugo Bellen, Professor of Special Services in Molecular and Human Genetics at Baylor University, said: "We found that APOE4 is actually unable to transfer lipids to glial cells, while the other two forms of APOE, APOE2 and APOE3, can effectively transfer
"In the current work, we want to identify genes that are essential for lipid droplet formation, especially those that are required for the export of lipids from neurons and the introduction of lipids into glial
The team studied the effects of these Alzheimer's disease risk genes on a fruit fly model, studying only one gene at a time
First author Dr.
In this way, the team demonstrated that several genes related to the risk of Alzheimer’s disease in the whole-genome sequencing study disrupted the formation of neuroprotective lipid droplets, which provided a mechanism that could explain the risks associated with these genes.
In addition, in the Drosophila model, Moulton and his colleagues tested whether the ABCA1 agonist can enable APOE4 in the Drosophila model to mediate the formation of lipid droplets in glial cells
The researchers also studied whether ROS can exacerbate the effects of amyloid on the disease
"As we age, the ROS in the brain will increase
Magazine
Proceedings of the National Academy of Sciences
DOI
10.